Cocrystal Pharma, Inc. (COCP) › Total AssetsCocrystal Pharma, Inc. (COCP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $7.53M2011: $7.55M2012: $7.24M2013: $1.66M2014: $259.28M2015: $224.23M2016: $124.88M2017: $121.43M2018: $68.56M2019: $28.53M2020: $54.24M2021: $79.39M2022: $40.84M2023: $31.26M2024: $13.46M2025: $9.71M$9.71M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$9.71M-27.8%2024$13.46M-57.0%2023$31.26M-23.5%2022$40.84M-48.6%2021$79.39M+46.4%2020$54.24M+90.1%2019$28.53M-58.4%2018$68.56M-43.5%2017$121.43M-2.8%2016$124.88M-44.3%2015$224.23M-13.5%2014$259.28M+15510.1%2013$1.66M-77.1%2012$7.24M-4.1%2011$7.55M+0.2%2010$7.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share